Rank | Gene Set | Z-score |
---|---|---|
1 | cullin deneddylation (GO:0010388) | 4.92216318 |
2 | ribosome assembly (GO:0042255) | 4.54906092 |
3 | establishment of integrated proviral latency (GO:0075713) | 4.36952940 |
4 | DNA double-strand break processing (GO:0000729) | 4.03100174 |
5 | purine nucleobase biosynthetic process (GO:0009113) | 3.90320715 |
6 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.89417742 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.88979466 |
8 | L-phenylalanine metabolic process (GO:0006558) | 3.88979466 |
9 | IMP biosynthetic process (GO:0006188) | 3.88173408 |
10 | protein neddylation (GO:0045116) | 3.86530346 |
11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.85134728 |
12 | ATP synthesis coupled proton transport (GO:0015986) | 3.85134728 |
13 | CENP-A containing nucleosome assembly (GO:0034080) | 3.84783782 |
14 | chromatin remodeling at centromere (GO:0031055) | 3.83015008 |
15 | L-phenylalanine catabolic process (GO:0006559) | 3.70894232 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.70894232 |
17 | lysine catabolic process (GO:0006554) | 3.59591443 |
18 | lysine metabolic process (GO:0006553) | 3.59591443 |
19 | glyoxylate metabolic process (GO:0046487) | 3.59272714 |
20 | ribonucleoprotein complex disassembly (GO:0032988) | 3.58227004 |
21 | organelle disassembly (GO:1903008) | 3.56761752 |
22 | chaperone-mediated protein transport (GO:0072321) | 3.51792154 |
23 | DNA damage response, detection of DNA damage (GO:0042769) | 3.51428105 |
24 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.45936736 |
25 | nucleobase biosynthetic process (GO:0046112) | 3.45136719 |
26 | rRNA modification (GO:0000154) | 3.44307022 |
27 | establishment of viral latency (GO:0019043) | 3.44195913 |
28 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.43577394 |
29 | DNA replication checkpoint (GO:0000076) | 3.38424848 |
30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.38064814 |
31 | regulation of ligase activity (GO:0051340) | 3.35652463 |
32 | tRNA aminoacylation for protein translation (GO:0006418) | 3.34507576 |
33 | tricarboxylic acid cycle (GO:0006099) | 3.33939347 |
34 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.32471524 |
35 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.32471524 |
36 | tRNA aminoacylation (GO:0043039) | 3.32407217 |
37 | amino acid activation (GO:0043038) | 3.32407217 |
38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.30708231 |
39 | respiratory chain complex IV assembly (GO:0008535) | 3.30069012 |
40 | DNA deamination (GO:0045006) | 3.29538471 |
41 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.26145929 |
42 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.23108065 |
43 | termination of RNA polymerase III transcription (GO:0006386) | 3.23108065 |
44 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.22490269 |
45 | DNA ligation (GO:0006266) | 3.21629376 |
46 | amino-acid betaine metabolic process (GO:0006577) | 3.19062238 |
47 | histone exchange (GO:0043486) | 3.18744662 |
48 | regulation of helicase activity (GO:0051095) | 3.17984379 |
49 | proteasome assembly (GO:0043248) | 3.17771705 |
50 | non-recombinational repair (GO:0000726) | 3.17167446 |
51 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.17167446 |
52 | cysteine metabolic process (GO:0006534) | 3.16798715 |
53 | mitotic metaphase plate congression (GO:0007080) | 3.15177231 |
54 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.14796108 |
55 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.14796108 |
56 | fatty acid beta-oxidation (GO:0006635) | 3.14528780 |
57 | protein K11-linked ubiquitination (GO:0070979) | 3.14356814 |
58 | histone mRNA metabolic process (GO:0008334) | 3.12915594 |
59 | valine metabolic process (GO:0006573) | 3.11306445 |
60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11171912 |
61 | respiratory electron transport chain (GO:0022904) | 3.10002527 |
62 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.09016171 |
63 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.09016171 |
64 | negative regulation of sister chromatid segregation (GO:0033046) | 3.09016171 |
65 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.09016171 |
66 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.09016171 |
67 | mitotic spindle checkpoint (GO:0071174) | 3.08309477 |
68 | protein targeting to mitochondrion (GO:0006626) | 3.07005447 |
69 | DNA replication-independent nucleosome organization (GO:0034724) | 3.06352348 |
70 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.06352348 |
71 | carnitine metabolic process (GO:0009437) | 3.05164270 |
72 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.05162108 |
73 | glycine metabolic process (GO:0006544) | 3.04923608 |
74 | aldehyde catabolic process (GO:0046185) | 3.03491935 |
75 | pseudouridine synthesis (GO:0001522) | 3.03243810 |
76 | negative regulation of protein ubiquitination (GO:0031397) | 3.03077727 |
77 | electron transport chain (GO:0022900) | 3.02809225 |
78 | spindle checkpoint (GO:0031577) | 3.01309051 |
79 | aromatic amino acid family catabolic process (GO:0009074) | 3.01265907 |
80 | rRNA methylation (GO:0031167) | 3.00981859 |
81 | negative regulation of chromosome segregation (GO:0051985) | 2.99554070 |
82 | oxidative phosphorylation (GO:0006119) | 2.99353785 |
83 | protein localization to mitochondrion (GO:0070585) | 2.99157804 |
84 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.97737368 |
85 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.97470327 |
86 | amino acid salvage (GO:0043102) | 2.96846341 |
87 | L-methionine salvage (GO:0071267) | 2.96846341 |
88 | L-methionine biosynthetic process (GO:0071265) | 2.96846341 |
89 | protein complex biogenesis (GO:0070271) | 2.96099955 |
90 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95885074 |
91 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.94061621 |
92 | NADH dehydrogenase complex assembly (GO:0010257) | 2.94061621 |
93 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.94061621 |
94 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93994567 |
95 | metaphase plate congression (GO:0051310) | 2.93069128 |
96 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.92741093 |
97 | serine family amino acid biosynthetic process (GO:0009070) | 2.91562985 |
98 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.91492581 |
99 | cell cycle G1/S phase transition (GO:0044843) | 2.91492581 |
100 | branched-chain amino acid catabolic process (GO:0009083) | 2.91206554 |
101 | ribosomal large subunit biogenesis (GO:0042273) | 2.89184491 |
102 | spliceosomal snRNP assembly (GO:0000387) | 2.88328010 |
103 | mitotic spindle assembly checkpoint (GO:0007094) | 2.88090784 |
104 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.87466769 |
105 | mitochondrial RNA metabolic process (GO:0000959) | 2.87368064 |
106 | bile acid biosynthetic process (GO:0006699) | 2.86830535 |
107 | inner mitochondrial membrane organization (GO:0007007) | 2.85897518 |
108 | coenzyme catabolic process (GO:0009109) | 2.84869015 |
109 | fatty acid oxidation (GO:0019395) | 2.80515252 |
110 | Golgi transport vesicle coating (GO:0048200) | 2.77883415 |
111 | COPI coating of Golgi vesicle (GO:0048205) | 2.77883415 |
112 | serine family amino acid metabolic process (GO:0009069) | 2.77386563 |
113 | fatty acid catabolic process (GO:0009062) | 2.76953904 |
114 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.75903129 |
115 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75813080 |
116 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75033286 |
117 | lipid oxidation (GO:0034440) | 2.74579650 |
118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73589540 |
119 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.70533833 |
120 | cofactor catabolic process (GO:0051187) | 2.69735371 |
121 | aspartate family amino acid catabolic process (GO:0009068) | 2.69416505 |
122 | protein deneddylation (GO:0000338) | 2.69140087 |
123 | branched-chain amino acid metabolic process (GO:0009081) | 2.68261085 |
124 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.68099412 |
125 | quinone biosynthetic process (GO:1901663) | 2.67813046 |
126 | ubiquinone biosynthetic process (GO:0006744) | 2.67813046 |
127 | tricarboxylic acid metabolic process (GO:0072350) | 2.66858376 |
128 | AMP metabolic process (GO:0046033) | 2.66677289 |
129 | sulfur amino acid catabolic process (GO:0000098) | 2.65848407 |
130 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.65652040 |
131 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.65652040 |
132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.65009234 |
133 | purine nucleotide salvage (GO:0032261) | 2.63389852 |
134 | regulation of mitochondrial translation (GO:0070129) | 2.61690817 |
135 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.60748575 |
136 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.60748575 |
137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.60748575 |
138 | aspartate family amino acid metabolic process (GO:0009066) | 2.60669227 |
139 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.60134523 |
140 | negative regulation of ligase activity (GO:0051352) | 2.59372383 |
141 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59372383 |
142 | negative regulation of fibrinolysis (GO:0051918) | 2.59159785 |
143 | sulfur amino acid biosynthetic process (GO:0000097) | 2.59028854 |
144 | signal peptide processing (GO:0006465) | 2.58842730 |
145 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58294528 |
146 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.57735549 |
147 | protein carboxylation (GO:0018214) | 2.57735549 |
148 | tetrahydrofolate metabolic process (GO:0046653) | 2.56582832 |
149 | acetyl-CoA metabolic process (GO:0006084) | 2.56502577 |
150 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.53112849 |
151 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.53112849 |
152 | cellular ketone body metabolic process (GO:0046950) | 2.53107819 |
153 | ubiquinone metabolic process (GO:0006743) | 2.52986452 |
154 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.52723698 |
155 | kynurenine metabolic process (GO:0070189) | 2.52402492 |
156 | formation of translation preinitiation complex (GO:0001731) | 2.52307152 |
157 | mitochondrial calcium ion transport (GO:0006851) | 2.51094558 |
158 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.48480842 |
159 | monocarboxylic acid catabolic process (GO:0072329) | 2.47804920 |
160 | indole-containing compound catabolic process (GO:0042436) | 2.47528177 |
161 | indolalkylamine catabolic process (GO:0046218) | 2.47528177 |
162 | tryptophan catabolic process (GO:0006569) | 2.47528177 |
163 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.47066908 |
164 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.46814989 |
165 | one-carbon metabolic process (GO:0006730) | 2.45986911 |
166 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.45902992 |
167 | tryptophan metabolic process (GO:0006568) | 2.44743199 |
168 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.43194852 |
169 | aromatic amino acid family metabolic process (GO:0009072) | 2.41589039 |
170 | S-adenosylmethionine metabolic process (GO:0046500) | 2.41356415 |
171 | serine family amino acid catabolic process (GO:0009071) | 2.40537945 |
172 | oxaloacetate metabolic process (GO:0006107) | 2.39558139 |
173 | positive regulation of ligase activity (GO:0051351) | 2.38968712 |
174 | IMP metabolic process (GO:0046040) | 2.38930246 |
175 | nucleoside salvage (GO:0043174) | 2.37855163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.57804938 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58577096 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.55323277 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.52608790 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.41410755 |
6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.37446391 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90983851 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85183380 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.81137521 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.79340327 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.74500495 |
12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71934636 |
13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.64537315 |
14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.55142149 |
15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.48486317 |
16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47276514 |
17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.43760034 |
18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.31586321 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31083374 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30550158 |
21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.25693446 |
22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.19663953 |
23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14816473 |
24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13499043 |
25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12592828 |
26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.07702678 |
27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01444945 |
28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99691978 |
29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98752873 |
30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91701818 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91468335 |
32 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.90861292 |
33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89041159 |
34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.88757962 |
35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84274506 |
36 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.84015018 |
37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.83955691 |
38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78258997 |
39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76591637 |
40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75514990 |
41 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74917407 |
42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72582717 |
43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72359907 |
44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.71361781 |
45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70890127 |
46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69545640 |
47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69353601 |
48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.69076695 |
49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64799251 |
50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64671442 |
51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.64444438 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52934562 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50072806 |
54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48576415 |
55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.46524596 |
56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44188818 |
57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42207452 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41448998 |
59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40493473 |
60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40163264 |
61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39745215 |
62 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.38482280 |
63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37780625 |
64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37075699 |
65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36604075 |
66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35156138 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35022075 |
68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34349537 |
69 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32207934 |
70 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.31688238 |
71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28263831 |
72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27183016 |
73 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.26666051 |
74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.23972461 |
75 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22889914 |
76 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.21257419 |
77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20843637 |
78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19046804 |
79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18236451 |
80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15593622 |
81 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14159407 |
82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11552423 |
83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11348400 |
84 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10894481 |
85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10712737 |
86 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08814210 |
87 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08545561 |
88 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08236575 |
89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05273535 |
90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05056090 |
91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04688815 |
92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04263896 |
93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03042391 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02322657 |
95 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01953321 |
96 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.01504945 |
97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01303054 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00920922 |
99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99795055 |
100 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99287719 |
101 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99108023 |
102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96527131 |
103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95831656 |
104 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94909561 |
105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94885389 |
106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94341353 |
107 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.94275485 |
108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93017794 |
109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92644154 |
110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92625045 |
111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91701406 |
112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91318856 |
113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90542310 |
114 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89297479 |
115 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.89295541 |
116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88083879 |
117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87412800 |
118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87384175 |
119 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.86618197 |
120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85744037 |
121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85540511 |
122 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85049447 |
123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84291830 |
124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83546329 |
125 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.83254468 |
126 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82338248 |
127 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81539743 |
128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.81153396 |
129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80742551 |
130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79460632 |
131 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.79458351 |
132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79386845 |
133 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.79151630 |
134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79008590 |
135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77651019 |
136 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.76888931 |
137 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.75714490 |
138 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75023035 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.79646594 |
2 | MP0003806_abnormal_nucleotide_metabolis | 4.64298286 |
3 | MP0005360_urolithiasis | 3.74860594 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.29522297 |
5 | MP0003941_abnormal_skin_development | 3.23453833 |
6 | MP0005365_abnormal_bile_salt | 3.17446172 |
7 | MP0002102_abnormal_ear_morphology | 2.76949544 |
8 | MP0003646_muscle_fatigue | 2.67167354 |
9 | MP0001529_abnormal_vocalization | 2.63361206 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.63197220 |
11 | MP0003693_abnormal_embryo_hatching | 2.55310417 |
12 | MP0003786_premature_aging | 2.47000054 |
13 | MP0006036_abnormal_mitochondrial_physio | 2.41391866 |
14 | MP0003186_abnormal_redox_activity | 2.38526957 |
15 | MP0003195_calcinosis | 2.26126448 |
16 | MP0008877_abnormal_DNA_methylation | 2.22483581 |
17 | MP0005451_abnormal_body_composition | 2.21462913 |
18 | MP0003890_abnormal_embryonic-extraembry | 2.20255250 |
19 | MP0002837_dystrophic_cardiac_calcinosis | 2.08809034 |
20 | MP0004957_abnormal_blastocyst_morpholog | 1.86056500 |
21 | MP0001666_abnormal_nutrient_absorption | 1.85352177 |
22 | MP0005083_abnormal_biliary_tract | 1.83923350 |
23 | MP0006072_abnormal_retinal_apoptosis | 1.83618115 |
24 | MP0001188_hyperpigmentation | 1.76885277 |
25 | MP0003656_abnormal_erythrocyte_physiolo | 1.74024360 |
26 | MP0005332_abnormal_amino_acid | 1.71965774 |
27 | MP0009697_abnormal_copulation | 1.71082510 |
28 | MP0008057_abnormal_DNA_replication | 1.69181087 |
29 | MP0003252_abnormal_bile_duct | 1.62586163 |
30 | MP0010329_abnormal_lipoprotein_level | 1.58872705 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.58838802 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.57678323 |
33 | MP0000749_muscle_degeneration | 1.55022434 |
34 | MP0006035_abnormal_mitochondrial_morpho | 1.52111451 |
35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.50351345 |
36 | MP0009840_abnormal_foam_cell | 1.44180069 |
37 | MP0002234_abnormal_pharynx_morphology | 1.41438068 |
38 | MP0002938_white_spotting | 1.39380829 |
39 | MP0005367_renal/urinary_system_phenotyp | 1.35857009 |
40 | MP0000516_abnormal_urinary_system | 1.35857009 |
41 | MP0000609_abnormal_liver_physiology | 1.35826622 |
42 | MP0000750_abnormal_muscle_regeneration | 1.35245683 |
43 | MP0008995_early_reproductive_senescence | 1.33394103 |
44 | MP0003315_abnormal_perineum_morphology | 1.32717876 |
45 | MP0005670_abnormal_white_adipose | 1.31354306 |
46 | MP0003718_maternal_effect | 1.30833878 |
47 | MP0005330_cardiomyopathy | 1.29581294 |
48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27467395 |
49 | MP0010352_gastrointestinal_tract_polyps | 1.24900983 |
50 | MP0003077_abnormal_cell_cycle | 1.23913563 |
51 | MP0001293_anophthalmia | 1.23155668 |
52 | MP0001764_abnormal_homeostasis | 1.23052550 |
53 | MP0009643_abnormal_urine_homeostasis | 1.20214537 |
54 | MP0002269_muscular_atrophy | 1.20035990 |
55 | MP0001697_abnormal_embryo_size | 1.19668660 |
56 | MP0005408_hypopigmentation | 1.16794392 |
57 | MP0003937_abnormal_limbs/digits/tail_de | 1.15743132 |
58 | MP0005636_abnormal_mineral_homeostasis | 1.13533088 |
59 | MP0000350_abnormal_cell_proliferation | 1.13327359 |
60 | MP0004084_abnormal_cardiac_muscle | 1.13229563 |
61 | MP0002118_abnormal_lipid_homeostasis | 1.12063763 |
62 | MP0008007_abnormal_cellular_replicative | 1.11628752 |
63 | MP0002751_abnormal_autonomic_nervous | 1.10267669 |
64 | MP0005380_embryogenesis_phenotype | 1.10231651 |
65 | MP0001672_abnormal_embryogenesis/_devel | 1.10231651 |
66 | MP0005645_abnormal_hypothalamus_physiol | 1.10032047 |
67 | MP0005075_abnormal_melanosome_morpholog | 1.09825405 |
68 | MP0005220_abnormal_exocrine_pancreas | 1.09674956 |
69 | MP0008932_abnormal_embryonic_tissue | 1.07853801 |
70 | MP0006054_spinal_hemorrhage | 1.07763013 |
71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07423816 |
72 | MP0008789_abnormal_olfactory_epithelium | 1.07386183 |
73 | MP0005266_abnormal_metabolism | 1.04776784 |
74 | MP0002084_abnormal_developmental_patter | 1.04543387 |
75 | MP0004036_abnormal_muscle_relaxation | 1.04163905 |
76 | MP0008438_abnormal_cutaneous_collagen | 1.04030100 |
77 | MP0003868_abnormal_feces_composition | 1.03850097 |
78 | MP0000598_abnormal_liver_morphology | 1.03579248 |
79 | MP0003123_paternal_imprinting | 1.03347621 |
80 | MP0000647_abnormal_sebaceous_gland | 1.01943786 |
81 | MP0002090_abnormal_vision | 1.00379356 |
82 | MP0001661_extended_life_span | 0.99923416 |
83 | MP0002233_abnormal_nose_morphology | 0.99913496 |
84 | MP0003119_abnormal_digestive_system | 0.99528529 |
85 | MP0001853_heart_inflammation | 0.99199087 |
86 | MP0002080_prenatal_lethality | 0.96613000 |
87 | MP0002085_abnormal_embryonic_tissue | 0.94775943 |
88 | MP0005253_abnormal_eye_physiology | 0.94692179 |
89 | MP0005275_abnormal_skin_tensile | 0.94119228 |
90 | MP0004215_abnormal_myocardial_fiber | 0.93953654 |
91 | MP0004147_increased_porphyrin_level | 0.91838926 |
92 | MP0010094_abnormal_chromosome_stability | 0.90638728 |
93 | MP0002138_abnormal_hepatobiliary_system | 0.89675464 |
94 | MP0000358_abnormal_cell_content/ | 0.89646649 |
95 | MP0001730_embryonic_growth_arrest | 0.89521326 |
96 | MP0005187_abnormal_penis_morphology | 0.88677113 |
97 | MP0010030_abnormal_orbit_morphology | 0.87605522 |
98 | MP0004087_abnormal_muscle_fiber | 0.86906582 |
99 | MP0003984_embryonic_growth_retardation | 0.86347395 |
100 | MP0005084_abnormal_gallbladder_morpholo | 0.85343808 |
101 | MP0002088_abnormal_embryonic_growth/wei | 0.84942799 |
102 | MP0003880_abnormal_central_pattern | 0.84112044 |
103 | MP0009053_abnormal_anal_canal | 0.83613893 |
104 | MP0001542_abnormal_bone_strength | 0.83560439 |
105 | MP0002106_abnormal_muscle_physiology | 0.83534886 |
106 | MP0008775_abnormal_heart_ventricle | 0.83025464 |
107 | MP0002160_abnormal_reproductive_system | 0.82887127 |
108 | MP0000751_myopathy | 0.82128583 |
109 | MP0004019_abnormal_vitamin_homeostasis | 0.81869529 |
110 | MP0001929_abnormal_gametogenesis | 0.80170518 |
111 | MP0003191_abnormal_cellular_cholesterol | 0.79738350 |
112 | MP0004782_abnormal_surfactant_physiolog | 0.79344702 |
113 | MP0002971_abnormal_brown_adipose | 0.78861148 |
114 | MP0001286_abnormal_eye_development | 0.78088455 |
115 | MP0000313_abnormal_cell_death | 0.77833025 |
116 | MP0002060_abnormal_skin_morphology | 0.77722120 |
117 | MP0004130_abnormal_muscle_cell | 0.77607846 |
118 | MP0002736_abnormal_nociception_after | 0.77301972 |
119 | MP0009672_abnormal_birth_weight | 0.76127612 |
120 | MP0010386_abnormal_urinary_bladder | 0.74669148 |
121 | MP0002254_reproductive_system_inflammat | 0.74373884 |
122 | MP0002210_abnormal_sex_determination | 0.73556714 |
123 | MP0008469_abnormal_protein_level | 0.73515398 |
124 | MP0003011_delayed_dark_adaptation | 0.73028893 |
125 | MP0009763_increased_sensitivity_to | 0.72696236 |
126 | MP0003121_genomic_imprinting | 0.72090560 |
127 | MP0008260_abnormal_autophagy | 0.71840370 |
128 | MP0003111_abnormal_nucleus_morphology | 0.70246825 |
129 | MP0002396_abnormal_hematopoietic_system | 0.70011926 |
130 | MP0003755_abnormal_palate_morphology | 0.69982635 |
131 | MP0001145_abnormal_male_reproductive | 0.69901373 |
132 | MP0002822_catalepsy | 0.69641520 |
133 | MP0001984_abnormal_olfaction | 0.68823443 |
134 | MP0001544_abnormal_cardiovascular_syste | 0.68822967 |
135 | MP0005385_cardiovascular_system_phenoty | 0.68822967 |
136 | MP0000653_abnormal_sex_gland | 0.68789010 |
137 | MP0001756_abnormal_urination | 0.67789049 |
138 | MP0002282_abnormal_trachea_morphology | 0.67758603 |
139 | MP0004145_abnormal_muscle_electrophysio | 0.67275711 |
140 | MP0005620_abnormal_muscle_contractility | 0.67207081 |
141 | MP0004197_abnormal_fetal_growth/weight/ | 0.66964185 |
142 | MP0003950_abnormal_plasma_membrane | 0.66794199 |
143 | MP0009703_decreased_birth_body | 0.66754948 |
144 | MP0005023_abnormal_wound_healing | 0.66738538 |
145 | MP0001243_abnormal_dermal_layer | 0.65832507 |
146 | MP0005376_homeostasis/metabolism_phenot | 0.65678699 |
147 | MP0008058_abnormal_DNA_repair | 0.65314568 |
148 | MP0005395_other_phenotype | 0.65237839 |
149 | MP0001299_abnormal_eye_distance/ | 0.65036547 |
150 | MP0009764_decreased_sensitivity_to | 0.63883388 |
151 | MP0000343_altered_response_to | 0.63582257 |
152 | MP0000759_abnormal_skeletal_muscle | 0.62821637 |
153 | MP0002019_abnormal_tumor_incidence | 0.62673886 |
154 | MP0003787_abnormal_imprinting | 0.62227540 |
155 | MP0005666_abnormal_adipose_tissue | 0.62139177 |
156 | MP0001727_abnormal_embryo_implantation | 0.61942191 |
157 | MP0002086_abnormal_extraembryonic_tissu | 0.61870429 |
158 | MP0000372_irregular_coat_pigmentation | 0.61234017 |
159 | MP0002078_abnormal_glucose_homeostasis | 0.60939167 |
160 | MP0001119_abnormal_female_reproductive | 0.60786901 |
161 | MP0003436_decreased_susceptibility_to | 0.60570710 |
162 | MP0005369_muscle_phenotype | 0.59938396 |
163 | MP0002111_abnormal_tail_morphology | 0.58887825 |
164 | MP0008872_abnormal_physiological_respon | 0.57227858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 4.52568678 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.41355051 |
3 | Increased hepatocellular lipid droplets (HP:0006565) | 4.35360652 |
4 | Hypobetalipoproteinemia (HP:0003563) | 3.95728611 |
5 | Hepatic necrosis (HP:0002605) | 3.85778828 |
6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64077261 |
7 | Hyperammonemia (HP:0001987) | 3.42535307 |
8 | Generalized aminoaciduria (HP:0002909) | 3.39388776 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.35412632 |
10 | Intrahepatic cholestasis (HP:0001406) | 3.35124633 |
11 | Rhabdomyolysis (HP:0003201) | 3.34350372 |
12 | Increased serum pyruvate (HP:0003542) | 3.34081878 |
13 | Abnormality of glycolysis (HP:0004366) | 3.34081878 |
14 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.30210575 |
15 | * Dicarboxylic aciduria (HP:0003215) | 3.30210575 |
16 | Ketosis (HP:0001946) | 3.23603725 |
17 | Acute encephalopathy (HP:0006846) | 3.21851524 |
18 | Renal Fanconi syndrome (HP:0001994) | 3.18447233 |
19 | Myoglobinuria (HP:0002913) | 3.17081708 |
20 | Cerebral edema (HP:0002181) | 3.15755521 |
21 | Hepatocellular necrosis (HP:0001404) | 3.08377187 |
22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.08351367 |
23 | Multiple enchondromatosis (HP:0005701) | 3.02875416 |
24 | Deep venous thrombosis (HP:0002625) | 3.00636814 |
25 | Colon cancer (HP:0003003) | 2.98460334 |
26 | Acute necrotizing encephalopathy (HP:0006965) | 2.97274672 |
27 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.94375266 |
28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.94204702 |
29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.94204702 |
30 | Nausea (HP:0002018) | 2.92916775 |
31 | Abnormality of the labia minora (HP:0012880) | 2.88405391 |
32 | Hyperglycinuria (HP:0003108) | 2.78575769 |
33 | Xanthomatosis (HP:0000991) | 2.78091846 |
34 | Prolonged partial thromboplastin time (HP:0003645) | 2.77837137 |
35 | Lactic acidosis (HP:0003128) | 2.76714887 |
36 | Ketoacidosis (HP:0001993) | 2.73817291 |
37 | Hypolipoproteinemia (HP:0010981) | 2.73549037 |
38 | * Lethargy (HP:0001254) | 2.70951752 |
39 | Increased CSF lactate (HP:0002490) | 2.70335764 |
40 | Proximal tubulopathy (HP:0000114) | 2.61724992 |
41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60604441 |
42 | Abnormality of glycine metabolism (HP:0010895) | 2.60604441 |
43 | Mitochondrial inheritance (HP:0001427) | 2.60069737 |
44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59294030 |
45 | Hyperglycinemia (HP:0002154) | 2.54094284 |
46 | Fat malabsorption (HP:0002630) | 2.53917703 |
47 | Increased serum lactate (HP:0002151) | 2.51945637 |
48 | Abnormal lung lobation (HP:0002101) | 2.51491943 |
49 | Exertional dyspnea (HP:0002875) | 2.51051170 |
50 | Metabolic acidosis (HP:0001942) | 2.50425601 |
51 | Microretrognathia (HP:0000308) | 2.49362178 |
52 | * Abnormality of serum amino acid levels (HP:0003112) | 2.48546676 |
53 | Ependymoma (HP:0002888) | 2.48396401 |
54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48384786 |
55 | Abnormality of alanine metabolism (HP:0010916) | 2.47102640 |
56 | Hyperalaninemia (HP:0003348) | 2.47102640 |
57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.47102640 |
58 | Malnutrition (HP:0004395) | 2.46786201 |
59 | Conjunctival hamartoma (HP:0100780) | 2.45964058 |
60 | Abnormal protein glycosylation (HP:0012346) | 2.45815379 |
61 | Abnormal glycosylation (HP:0012345) | 2.45815379 |
62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.45815379 |
63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.45815379 |
64 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43112449 |
65 | Abnormal cartilage morphology (HP:0002763) | 2.42271040 |
66 | Hyperbilirubinemia (HP:0002904) | 2.41645443 |
67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.41600960 |
68 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41530770 |
69 | Reduced antithrombin III activity (HP:0001976) | 2.39223019 |
70 | Exercise-induced muscle cramps (HP:0003710) | 2.37287740 |
71 | Steatorrhea (HP:0002570) | 2.35766080 |
72 | * Abnormality of methionine metabolism (HP:0010901) | 2.35222751 |
73 | Increased muscle lipid content (HP:0009058) | 2.33959810 |
74 | Opisthotonus (HP:0002179) | 2.31794919 |
75 | Hyperlipoproteinemia (HP:0010980) | 2.30954499 |
76 | Muscle fiber inclusion bodies (HP:0100299) | 2.30084222 |
77 | Microvesicular hepatic steatosis (HP:0001414) | 2.29522625 |
78 | Birth length less than 3rd percentile (HP:0003561) | 2.28214266 |
79 | Abnormality of the anterior horn cell (HP:0006802) | 2.26049823 |
80 | Degeneration of anterior horn cells (HP:0002398) | 2.26049823 |
81 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.24154963 |
82 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23974268 |
83 | Amniotic constriction ring (HP:0009775) | 2.23487163 |
84 | Abnormality of placental membranes (HP:0011409) | 2.23487163 |
85 | Glycosuria (HP:0003076) | 2.23060546 |
86 | Abnormality of urine glucose concentration (HP:0011016) | 2.23060546 |
87 | Progressive macrocephaly (HP:0004481) | 2.22751545 |
88 | Palpitations (HP:0001962) | 2.22423354 |
89 | Respiratory failure (HP:0002878) | 2.20897519 |
90 | Lipid accumulation in hepatocytes (HP:0006561) | 2.20709525 |
91 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20333382 |
92 | Neoplasm of the colon (HP:0100273) | 2.18964731 |
93 | Congenital, generalized hypertrichosis (HP:0004540) | 2.15419089 |
94 | Nemaline bodies (HP:0003798) | 2.15045190 |
95 | Abnormality of chromosome stability (HP:0003220) | 2.14189877 |
96 | Gout (HP:0001997) | 2.13954080 |
97 | Respiratory difficulties (HP:0002880) | 2.12715297 |
98 | Meckel diverticulum (HP:0002245) | 2.11851617 |
99 | Leukodystrophy (HP:0002415) | 2.10283664 |
100 | Late onset (HP:0003584) | 2.09963189 |
101 | Exercise intolerance (HP:0003546) | 2.08782834 |
102 | Oral leukoplakia (HP:0002745) | 2.08655871 |
103 | Vomiting (HP:0002013) | 2.08236076 |
104 | Spastic diplegia (HP:0001264) | 2.06612768 |
105 | Optic disc pallor (HP:0000543) | 2.04844772 |
106 | Chromsome breakage (HP:0040012) | 2.04513921 |
107 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03994567 |
108 | Ragged-red muscle fibers (HP:0003200) | 2.03565383 |
109 | Poor head control (HP:0002421) | 2.02703463 |
110 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01905974 |
111 | Abnormality of purine metabolism (HP:0004352) | 2.01472894 |
112 | * Methylmalonic acidemia (HP:0002912) | 1.99864816 |
113 | Cerebral hypomyelination (HP:0006808) | 1.99809271 |
114 | Type I transferrin isoform profile (HP:0003642) | 1.99470802 |
115 | Hypoalphalipoproteinemia (HP:0003233) | 1.99363880 |
116 | Abnormality of the ileum (HP:0001549) | 1.98965005 |
117 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98423914 |
118 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97750316 |
119 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94795785 |
120 | Exercise-induced myalgia (HP:0003738) | 1.94053658 |
121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93506387 |
122 | Abnormality of the preputium (HP:0100587) | 1.92757132 |
123 | Hypoglycemic seizures (HP:0002173) | 1.92602228 |
124 | Increased intramyocellular lipid droplets (HP:0012240) | 1.91411477 |
125 | Gonadotropin excess (HP:0000837) | 1.90833048 |
126 | Hypothermia (HP:0002045) | 1.90671696 |
127 | Neoplasm of the adrenal gland (HP:0100631) | 1.90317028 |
128 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90305159 |
129 | CNS demyelination (HP:0007305) | 1.89548960 |
130 | Stenosis of the external auditory canal (HP:0000402) | 1.89483671 |
131 | Abnormality of renal resorption (HP:0011038) | 1.89024870 |
132 | Postnatal microcephaly (HP:0005484) | 1.88977858 |
133 | Medulloblastoma (HP:0002885) | 1.86192217 |
134 | Embryonal renal neoplasm (HP:0011794) | 1.84583738 |
135 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.83678033 |
136 | Rhabdomyosarcoma (HP:0002859) | 1.83674530 |
137 | Aplastic anemia (HP:0001915) | 1.81846105 |
138 | Medial flaring of the eyebrow (HP:0010747) | 1.81837998 |
139 | Small intestinal stenosis (HP:0012848) | 1.81722715 |
140 | Duodenal stenosis (HP:0100867) | 1.81722715 |
141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81591172 |
142 | Delayed CNS myelination (HP:0002188) | 1.76947006 |
143 | Abnormal gallbladder morphology (HP:0012437) | 1.76871261 |
144 | Cholecystitis (HP:0001082) | 1.75034468 |
145 | Abnormal gallbladder physiology (HP:0012438) | 1.75034468 |
146 | Sparse eyelashes (HP:0000653) | 1.74880437 |
147 | Increased serum ferritin (HP:0003281) | 1.74345308 |
148 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74148371 |
149 | Cholelithiasis (HP:0001081) | 1.73831968 |
150 | Median cleft lip (HP:0000161) | 1.73616247 |
151 | Bifid tongue (HP:0010297) | 1.72850285 |
152 | Secondary amenorrhea (HP:0000869) | 1.70868117 |
153 | Neoplasm of the small intestine (HP:0100833) | 1.69099299 |
154 | Shoulder girdle muscle weakness (HP:0003547) | 1.68856839 |
155 | Cortical dysplasia (HP:0002539) | 1.68347138 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.13187235 |
2 | NME2 | 3.54528616 |
3 | BUB1 | 3.08100591 |
4 | TRIM28 | 2.87004586 |
5 | TSSK6 | 2.68087486 |
6 | EIF2AK1 | 2.62918112 |
7 | PKN2 | 2.56993768 |
8 | VRK2 | 2.56993391 |
9 | STK16 | 2.52962777 |
10 | PDK4 | 2.36099443 |
11 | PDK3 | 2.36099443 |
12 | ERN1 | 2.23082679 |
13 | PBK | 2.13877668 |
14 | FLT3 | 2.12541665 |
15 | ACVR1B | 2.10715009 |
16 | MAP3K12 | 2.10279948 |
17 | NUAK1 | 1.98823478 |
18 | BCR | 1.97944238 |
19 | MAP4K2 | 1.93015985 |
20 | TESK1 | 1.92432880 |
21 | BRSK2 | 1.85765772 |
22 | OBSCN | 1.84006750 |
23 | WEE1 | 1.80868521 |
24 | NEK9 | 1.74660557 |
25 | EIF2AK3 | 1.72530540 |
26 | STK38L | 1.66373857 |
27 | TTN | 1.63647577 |
28 | NEK1 | 1.59680709 |
29 | ERBB3 | 1.54385689 |
30 | PLK4 | 1.53606947 |
31 | TESK2 | 1.50589912 |
32 | MAP3K3 | 1.47535757 |
33 | RPS6KA4 | 1.46001684 |
34 | MAP3K4 | 1.44712489 |
35 | ABL2 | 1.43619495 |
36 | MUSK | 1.43168659 |
37 | TGFBR1 | 1.41443426 |
38 | PIM2 | 1.39275645 |
39 | ERBB4 | 1.37614285 |
40 | CDC7 | 1.36260042 |
41 | TAF1 | 1.34286445 |
42 | MAPKAPK3 | 1.33296472 |
43 | BRAF | 1.31093318 |
44 | PIK3CG | 1.29389396 |
45 | KDR | 1.27408758 |
46 | LATS1 | 1.24604433 |
47 | MAP3K11 | 1.21936303 |
48 | TRIB3 | 1.21125307 |
49 | TNIK | 1.19604239 |
50 | LIMK1 | 1.18154004 |
51 | NEK2 | 1.17048498 |
52 | NME1 | 1.16596943 |
53 | MAP2K7 | 1.14398958 |
54 | MKNK1 | 1.14346113 |
55 | EIF2AK2 | 1.12000614 |
56 | CLK1 | 1.10103044 |
57 | MAP2K3 | 1.05466909 |
58 | AURKA | 1.02117609 |
59 | PDK2 | 1.00293290 |
60 | CSNK1G3 | 0.99549771 |
61 | CSNK1G1 | 0.98874987 |
62 | TTK | 0.98539863 |
63 | PASK | 0.94369340 |
64 | CSNK1G2 | 0.89382699 |
65 | MKNK2 | 0.87974519 |
66 | LATS2 | 0.87836065 |
67 | ARAF | 0.87806544 |
68 | MYLK | 0.85884283 |
69 | DYRK3 | 0.85147052 |
70 | PLK2 | 0.82981159 |
71 | RPS6KB2 | 0.81065324 |
72 | AURKB | 0.80640891 |
73 | CSNK1A1L | 0.80499903 |
74 | BRSK1 | 0.79588138 |
75 | BMPR1B | 0.79323589 |
76 | FRK | 0.79092282 |
77 | MAP3K8 | 0.76678123 |
78 | SRPK1 | 0.76431224 |
79 | SCYL2 | 0.75671360 |
80 | PLK1 | 0.74868563 |
81 | LRRK2 | 0.72410623 |
82 | TYK2 | 0.72225924 |
83 | GRK1 | 0.68410271 |
84 | DYRK1B | 0.68227177 |
85 | VRK1 | 0.66545135 |
86 | MAP3K5 | 0.65920838 |
87 | CHEK2 | 0.65499846 |
88 | NLK | 0.63912340 |
89 | STK3 | 0.63593172 |
90 | MOS | 0.63566348 |
91 | CDK8 | 0.62982435 |
92 | PAK4 | 0.60524120 |
93 | DYRK2 | 0.59487775 |
94 | ATM | 0.57789857 |
95 | STK10 | 0.56240976 |
96 | PIK3CA | 0.55557578 |
97 | OXSR1 | 0.54608575 |
98 | CCNB1 | 0.53911358 |
99 | STK24 | 0.53373252 |
100 | TBK1 | 0.52441930 |
101 | KSR2 | 0.52218353 |
102 | RAF1 | 0.51818892 |
103 | STK4 | 0.51246827 |
104 | MAPK13 | 0.50142483 |
105 | ILK | 0.49751544 |
106 | BMPR2 | 0.49602778 |
107 | CSNK2A2 | 0.48673933 |
108 | DAPK1 | 0.47659130 |
109 | ZAK | 0.47094946 |
110 | MAP2K1 | 0.46745205 |
111 | MST4 | 0.45788221 |
112 | MINK1 | 0.45742377 |
113 | SIK3 | 0.44969679 |
114 | IRAK3 | 0.44754102 |
115 | MET | 0.43107721 |
116 | CDK7 | 0.42921025 |
117 | CDK4 | 0.42515160 |
118 | CSNK2A1 | 0.42198451 |
119 | MAPK11 | 0.41815039 |
120 | MAPKAPK5 | 0.41715402 |
121 | RPS6KA5 | 0.41599499 |
122 | TRPM7 | 0.41398445 |
123 | WNK3 | 0.40513233 |
124 | PAK1 | 0.40417735 |
125 | ALK | 0.39959512 |
126 | TLK1 | 0.39591545 |
127 | FER | 0.39341961 |
128 | CHEK1 | 0.36974040 |
129 | FGFR1 | 0.36456052 |
130 | CSNK1E | 0.36420032 |
131 | TEC | 0.36288898 |
132 | STK39 | 0.36282481 |
133 | ATR | 0.36145466 |
134 | PRKCE | 0.35647679 |
135 | MST1R | 0.34250179 |
136 | WNK4 | 0.33802253 |
137 | ZAP70 | 0.33217489 |
138 | TGFBR2 | 0.30631375 |
139 | TAOK2 | 0.29155359 |
140 | PLK3 | 0.28477206 |
141 | PAK3 | 0.27867592 |
142 | CDK6 | 0.25478713 |
143 | CASK | 0.24011850 |
144 | INSRR | 0.23503813 |
145 | DAPK3 | 0.20871256 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 2.85088229 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.77543856 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47024110 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.38467730 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28821203 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26282006 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26077448 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17865849 |
9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01495857 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.89540253 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88547058 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 1.88293616 |
13 | Protein export_Homo sapiens_hsa03060 | 1.86865134 |
14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86758183 |
15 | Peroxisome_Homo sapiens_hsa04146 | 1.86613381 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80143707 |
17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74676270 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70723224 |
19 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70280053 |
20 | DNA replication_Homo sapiens_hsa03030 | 1.69071869 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66921669 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60428163 |
23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58066404 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56867802 |
25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56584920 |
26 | Ribosome_Homo sapiens_hsa03010 | 1.54928074 |
27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47311336 |
28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46157418 |
29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44393092 |
30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42037133 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39529076 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37654899 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.36730453 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35209149 |
35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34215321 |
36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33775577 |
37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33005911 |
38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32920462 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31032176 |
40 | Base excision repair_Homo sapiens_hsa03410 | 1.30330953 |
41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26903498 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23755514 |
43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21886417 |
44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17284774 |
45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16517165 |
46 | RNA polymerase_Homo sapiens_hsa03020 | 1.15756879 |
47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15533569 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14108649 |
49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13571644 |
50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13483173 |
51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11402298 |
52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10600333 |
53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08152400 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07966520 |
55 | Mismatch repair_Homo sapiens_hsa03430 | 1.06526655 |
56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06174738 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05695783 |
58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03880989 |
59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02127340 |
60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01962018 |
61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00776224 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00159524 |
63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95075916 |
64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94664846 |
65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94388175 |
66 | RNA transport_Homo sapiens_hsa03013 | 0.90675508 |
67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90391975 |
68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86342757 |
69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86295052 |
70 | Homologous recombination_Homo sapiens_hsa03440 | 0.83742438 |
71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.83275896 |
72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82993152 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82429710 |
74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82309315 |
75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81147290 |
76 | Spliceosome_Homo sapiens_hsa03040 | 0.81038656 |
77 | Cell cycle_Homo sapiens_hsa04110 | 0.80791224 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79501721 |
79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79410101 |
80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78816977 |
81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78223739 |
82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77677589 |
83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75732323 |
84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72330717 |
85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72328218 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71318524 |
87 | RNA degradation_Homo sapiens_hsa03018 | 0.70727127 |
88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69356778 |
89 | Legionellosis_Homo sapiens_hsa05134 | 0.66543385 |
90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66300452 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64694258 |
92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63761558 |
93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62839448 |
94 | Purine metabolism_Homo sapiens_hsa00230 | 0.59861082 |
95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58876381 |
96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52210338 |
97 | Phototransduction_Homo sapiens_hsa04744 | 0.46101481 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43410772 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42902736 |
100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38259530 |
101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35943671 |
102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35539485 |
103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35414075 |
104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34044561 |
105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33358353 |
106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32015254 |
107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31877834 |
108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29539894 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28248796 |
110 | ABC transporters_Homo sapiens_hsa02010 | 0.28154863 |
111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26353355 |
112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26106198 |
113 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25921132 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23161319 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21920203 |
116 | Alcoholism_Homo sapiens_hsa05034 | 0.20551532 |
117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.14167109 |
118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.13713405 |